Bob Oliver - Feb 25, 2025 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
Director
Signature
/s/ Nina Ayer, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Feb 25, 2025
Transactions value $
-$402,567
Form type
4
Date filed
2/26/2025, 08:00 PM
Previous filing
Jun 4, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $292K +15.1K +40.92% $19.28 52.2K Feb 25, 2025 Direct F1
transaction EXEL Common Stock Sale -$695K -18.6K -35.75% $37.25 33.5K Feb 25, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -15.1K -41.67% $0.00 21.2K Feb 25, 2025 Common Stock 15.1K $19.28 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 32,470 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2 The option, representing the right to purchase a total of 36,353 shares of Common Stock, became fully exercisable on May 31, 2023.